Cutaneous Oncology

Top Story

Delayed Mohs surgery does not impact complication risk

September 15, 2017

The timing of Mohs micrographic reconstructive surgery had no impact on infection risk or flap failure, according to recent findings.

The researchers suggested that while a delay to reconstructive surgery time may allow for planning and blood flow to the wound bed, some evidence has suggested that a delay of more than 2 days may increase complications in the post-operative setting.

Novel AI imaging approach yields improved skin cancer diagnosis

September 13, 2017
A novel imaging approach using artificial intelligence was associated with improved detection of parameters associated with melanoma, according to results presented at…
FDA News

FDA accepts application for binimetinib-encorafenib combination for BRAF-mutated melanoma

September 13, 2017
The FDA accepted for review new drug applications that seek the use of the COMBO450 regimen to treat patients with BRAF-mutant advanced, unresectable or metastatic…
Meeting News

Adjuvant vemurafenib confers clinical benefit in resected BRAF V600-positive melanoma

September 11, 2017
MADRID — Adjuvant vemurafenib conferred substantial clinical benefit to patients with completely resected stage IIC to stage IIIB BRAF V600-positive melanoma at…
More Headlines »